New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'

An anti-COVID oral drug developed by the DRDO has been approved by the Drugs Controller General of India (DCGI) for emergency use as an adjunct therapy in moderate to severe coronavirus patients. Clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Watch the video to know more.

New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'

Explore News